Anastomosis Devices Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024 - 2030)

Anastomosis Devices Market Size

Anastomosis Devices Market Trends & Drivers

Upsurge in Number of Operations Performed Globally Drives the Market Growth

A surge in the number of operations performed globally is likely to fuel the growth of the industry. This is because of the worldwide increase in the senior population and a rise in the prevalence of lifestyle diseases such as cancer, diabetes, hypertension, obesity, and heart illnesses. Thus, the demand for anastomosis systems is expected to increase along with the rising number of these surgeries. Also, these tools facilitate less scarring, quicker healing, and less blood loss.

In addition, surgeons perform techniques using extremely minimally invasive methods, and these instruments are particularly useful in treating cardiovascular conditions. Thus, medical experts can execute surgeries with high precision by using such equipment, as these devices can make an operation safe and reliable even in the most complicated parts of the heart, which will further encourage their adoption.

The use of these appliances further minimizes the need for a number of elements that can lead to suboptimal patient outcomes, such as induced hypothermic cardiac arrest, extracorporeal circulatory support, and aortic cross-clamping, on top of that they also aid in making the mechanics of the processes simpler for medical professionals.

Anastomosis Devices Market Analysis

Disposable Category Dominates the Industry

The disposable category dominated the market by holding the larger revenue share, around 80%, in 2022. This is due to a wider range of these items being offered and increased marketplace penetration. In addition, a large number of major players are engaged in the manufacture of disposable items.

Furthermore, these products lessen the possibility of SSI, cross-contamination, and other infections linked to healthcare. These disposable instruments also have the benefit of not needing to be reprocessed in between applications, which lowers reprocessing costs and expedites the overall procedures. Hence, the aforesaid advantages will drive the market in this category at a steady rate.

Cardiovascular and Thoracic Surgeries Category To Maintain its Dominance in Application Classification

Based on application, the cardiovascular and thoracic surgeries category accounted for the largest revenue share, over 60%, in 2022. This is because of the constant surge in the prevalence of CVDs, which are a key contributor to the rise in the number of heart surgeries. According to the WHO, there are approximately 17.9 million deaths occur due to CVDs.

On the other hand, due to the rising incidence of colorectal cancer and other gastrointestinal disorders that necessitate bowel resection, the gastrointestinal surgeries category, which includes large bowel resections and colorectal procedures, is expected to experience substantial growth of CAGR around 10% over the projected period.

Since colorectal cancer is becoming more common in the APAC region, the market has tremendous potential. It also noted that over the past 10 years, its incidence has increased two-to-four times in East Asian nations like Japan, China, South Korea, and Singapore. Additionally, a sizable number of items for usage in gastrointestinal anastomosis are projected to be introduced in the market throughout the projection period, offering several opportunities to industry players.

New Launches To Significantly Contribute To the Success of the Industry

In order to achieve a significant share and a competitive advantage, top competitors have raised their prospects through strategic alliances and collaborations and are working toward the introduction of new releases. For instance:

• The SureForm 45 Stapler from Intuitive Surgical was given FDA approval on January 18, 2019.
• Baxter International Inc. purchased the Pharmaceutical’s PREVELEAK Surgical Sealant and RECOTHROM Surgical Hemostat and Sealant Portfolio from Mallinckrodt Pharmaceutical on March 19, 2018. With this acquisition, Baxter's selection of enhanced surgical sealants was expanded.

Regional Analysis

North America Is Largest Revenue Contributor

North America accounted for the largest revenue share, around 45%, in 2022. Multiple cardiovascular indications, such as CAD and strokes, and gastric malignancies, such as adenocarcinoma and lymphoma, are becoming more prevalent in the region, which has led to an increase in procedures and a consequent rise in the need for anastomosis systems.

Moreover, according to statistics released in January 2020 by the American Heart Association, approximately half of the people in the U.S. has a cardiovascular condition of some kind, such as cardiac disease and hypertension. Thus, these instruments for monitoring and diagnosing cardiovascular systems became necessary as heart diseases became more widespread. In addition, the growing elderly population with chronic illnesses and deskbound lifestyles is significantly contributing to the development of the regional market.

Furthermore, due to the rise in severe disorders brought on by the aging population, there is a corresponding rise in the demand for surgeries, which is responsible for the high usage of anastomosis devices in the region.

Europe is the second largest market for anastomosis devices, accounting for 30% of the market in 2022. The growth in the market is mainly attributable to the increasing aging population; rising prevalence of chronic diseases; presence of established players; and rapid number of product launches in the region.

Additionally, the European region has reported increasing number of hospitals and surgical centers where anastomosis devices are more common. There are many number of hospitals are planned to be inaugurated in the upcoming years which are expected to increase various types of systems and anastomosis devices.

Germany, France and the U.K. are cumulatively holding around 50% of the European anastomosis devices market. Companies in these countries are actively involved in developing innovative and advanced products to cater the demand. Moreover, these nations also have well-developed healthcare infrastructure which are equipped with all large-to-small sized systems including anastomosis devices.

Market Breakdown

The report analyzes the impact of the major drivers and restraints on the anastomosis devices market, to offer accurate market estimations for 2019–2030.

Based on Type

• Disposable
• Reusable

Based on Product Type

• Staplers
  • Manual
  • Powered
• Sutures
  • Absorbable
    • Synthetic
    • Natural
  • Non-absorbable
  • Automated suturing devices
• Sealants & Adhesives
  • Biological
  • Synthetic 

Based on Application

• Gastrointestinal Surgeries
• Cardiovascular & Thoracic Surgeries

Based on End User

• Hospitals
• Ambulatory Surgery Centers & Clinics

Geographical Analysis

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
• Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • U.A.E.

Top Anastomosis Devices Companies